Comparing Demant A/S (OTCMKTS:WILYY) and Sanuwave Health (NASDAQ:SNWV)

Sanuwave Health (NASDAQ:SNWV) and Demant A/S (OTCMKTS:WILYY) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, analyst recommendations, earnings, risk and profitability.

Profitability

This table compares Sanuwave Health and Demant A/S’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sanuwave Health	-97.03%	N/A	-135.15%
Demant A/S	N/A	N/A	N/A

Valuation and Earnings

This table compares Sanuwave Health and Demant A/S”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sanuwave Health	$41.28 million	6.85	-$31.37 million	($1.30)	-25.36
Demant A/S	$3.25 billion	2.26	$346.11 million	N/A	N/A

Demant A/S has higher revenue and earnings than Sanuwave Health.

Volatility & Risk

Sanuwave Health has a beta of 1.22, suggesting that its stock price is 22% more volatile than the S&P 500. Comparatively, Demant A/S has a beta of 1.05, suggesting that its stock price is 5% more volatile than the S&P 500.

Insider & Institutional Ownership

42.5% of Sanuwave Health shares are held by institutional investors. 14.9% of Sanuwave Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Sanuwave Health and Demant A/S, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sanuwave Health	1	0	2	1	2.75
Demant A/S	0	1	0	1	3.00

Sanuwave Health presently has a consensus price target of $54.00, suggesting a potential upside of 63.79%. Given Sanuwave Health’s higher possible upside, analysts clearly believe Sanuwave Health is more favorable than Demant A/S.

Summary

Sanuwave Health beats Demant A/S on 6 of the 11 factors compared between the two stocks.

About Sanuwave Health

SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures. The company’s lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body’s normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures. The company was founded in 2005 and is headquartered in Suwanee, Georgia.

About Demant A/S

Demant A/S operates as a hearing healthcare and audio technology company in Europe, North America, the Asia Pacific, Asia, and internationally. It operates through two segments: Hearing Healthcare and Communications. The Hearing Healthcare segment is involved in the manufacturing, servicing, and sale of hearing aids, and diagnostic products and services. The Communications segment provides headsets and solutions for the professional call centers, office markets, and gaming markets under the EPOS brand name. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.